Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis

  • Luiz Derwal Salles Junior1,
  • Paulo Roberto Santos1Email author,
  • Armênio Aguiar dos Santos2 and
  • Marcellus Henrique Loiola Ponte de Souza2
BMC Nephrology201314:275

https://doi.org/10.1186/1471-2369-14-275

Received: 18 August 2013

Accepted: 11 December 2013

Published: 14 December 2013

Abstract

Background

Dyspepsia is common among end-stage renal disease (ESRD) patients and its association with delayed gastric emptying is not well established. We assessed the association of dyspepsia with gastric emptying time in ESRD patients undergoing hemodialysis (HD).

Methods

Dyspepsia was assessed through the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). PADYQ’s scores ≥ 6 classified participants as dyspeptic. The octanoic acid breath test using 13carbon was employed to assess the gastric emptying time. Based on the test, time in minutes to metabolize the first half of the 13carbon in the test meal (t1/2) was calculated. Association of dyspepsia with gastric emptying time was tested by the correlation between PADYQ scores and t1/2, and also by comparing t1/2 between dyspeptics and non-dyspeptics.

Results

There were 34 (68.0%) dyspeptic patients. Dyspepsia score was positively correlated with t1/2 (r = 0.366; p = 0.009). Dyspeptics had longer t1/2 compared to non-dyspeptics, respectively, 238.0 ± 92.9 versus 185.5 ± 45.5 minutes (p = 0.042).

Conclusions

Delayed gastric emptying was associated with dyspepsia. Prokinetic medications could have a role in preventing or relieving dyspeptic symptoms among HD patients. Future research in larger samples is necessary to confirm this association.

Keywords

End-stage renal disease Hemodialysis Dyspepsia Gastric motility Delayed gastric emptying

Background

The most common non-renal complaints in end-stage renal disease (ESRD) patients are gastrointestinal symptoms such as heartburn, constipation, diarrhea and dyspepsia [1]. Dyspepsia is highly prevalent and characterized by upper abdominal pain, nausea, vomiting, upper abdominal bloating, and early satiety [2]. The prevalence of dyspepsia among HD patients varies between 48% and 70% [3, 4]. In the general population, dyspepsia has been shown to impair quality of life [5]. Nevertheless, dyspeptic symptoms are not widely investigated among patients treated by HD, as is usually the case in relation to cardiovascular disease, osteodystrophy and nutritional status.

Dyspepsia may have organic and functional causes. Like in the general population, functional dyspepsia is the most frequent among ESRD patients [6]. There are reports of the possible role of gastric emptying delay as a cause of dyspeptic symptoms in HD patients [3]. Gastroparesis is better recognized in diabetics. However, its presence is also high in all-cause ESRD, varying between 36% to 62% among patients undergoing chronic HD [3, 7]. In these patients, delay in gastric emptying can be related to malnutrition and hormonal and electrolytic disturbances [8].

Dyspepsia can be easily evaluated through a questionnaire about characteristic symptoms, although gastric emptying time is not so easily assessed. The tools available to estimate gastric emptying time are: technetium-99 m scintigraphy (gold –pattern) [9]; time of appearance of acetaminophen in blood after its ingestion [10]; imaging studies using 3D ultrasonography and nuclear resonance [11, 12]; the smart pill (which seems to be a practical and promising method) [13]; and octanoic acid breath test using 13carbon (with 89% sensitivity compared to gold-standard technetium-99 m scintigraphy) [14].

In our study, we looked for an association between dyspepsia and gastric emptying time in an experiment conducted with a sample of ESRD patients on maintenance HD.

Methods

Sample

Fifty ESRD patients were randomly selected from a total of 225 patients undergoing HD in a single dialysis center during October 2011, after excluding patients: (i) under 18 years old, (ii) with less than three months of maintenance HD, (iii) with a history of abdominal surgery, chronic obstructive lung disease or chronic hepatic disease, (iv) with gallstone by ultrasonography, and (v) with endoscopy showing gastric ulcer, inflammation or structural alterations. Written informed consent was obtained from all participants, and the study was approved by the ethics committee of Federal University of Ceará.

Dyspepsia assessment

Dyspepsia was assessed using a validated Brazilian version of a standardized questionnaire named the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ) [2]. PADYQ allows quantitative analysis of symptoms of dyspepsia not related to ulcer and in accordance with the Rome I Consensus. It contains 11 questions about the presence, frequency, duration and intensity of five symptoms: upper abdominal pain, nausea, vomiting, upper abdominal bloating, and early satiety. Subjects were asked about the occurrence of these symptoms in the previous 30 days. Maximum score of 44. A score ≥ 6 classified the subject as dyspeptic. The assessment was administered by a single interviewer who was not a member of the regular dialysis unit team.

Gastric emptying time assessment

Patients were instructed to avoid smoking and eating food rich in C-4 plants, like corn (including baked goods made with cornmeal) and pineapples, in the week before the study. After a minimum of 10 hours of fasting and immediately before the intermediate weekly session of HD, all patients completed the octanoic acid breath test was performed [14]. They were instructed to eat a solid meal, consisting of a scrambled egg with the yolk labeled with 100 μg of 13carbon octanoic acid. After homogenizing the yolk, the egg white was added, beaten and baked. It was ingested with 60 g of white bread and 5 g of margarine during 1 to 5 min and followed immediately by 150 mL of water.

To collect the breath samples, the patients exhaled into closed aluminized plastic bags, before the test meal (baseline), and then at 15-minute intervals during 2 hours and then every 30 min for a further 2 hours. The patients were advised to remain seated and refrain from physical activity during the test [15].

The gastric emptying rate was defined by half-emptying time (t1/2). T1/2 is the time in minutes for the first half of the 13carbon dose in the test meal to be metabolized. The t1/2 was calculated as described by Ghoos et al. [14]. Accordingly, t1/2 of more than 200 minutes identified gastric emptying delay. Both the apparatus (IRIS II-13C-Breath Test System) and substrate (13C-octanoic acid) used here were supplied by Wagner Analysen Technik (Bremen, Germany).

Patient data

The demographic data, length of time on dialysis, number of current medications, use of antacids and underlying etiology of ESRD were obtained from the renal unit medical records. The underlying renal disease was classified according to clinical criteria only. Body mass index was calculated as Kg/m2. All participants completed laboratory tests for serum creatinine, albumin, hemoglobin, calcium and phosphorus were performed. The dose of dialysis delivered was evaluated using a second-generation Kt/V equation by Daugirdas [16].

Statistical analyses

Data are mean ± SD or percentage. Comparisons were performed by the Student-t and Mann-Whitney tests for continuous variables, respectively with or without normal distribution. Comparisons of frequencies were carried out by the Fisher test. The Pearson test, adjusted to traditional HD sample confounders (age, gender, diabetes, time on dialysis, hemoglobin, albumin and Kt/V), was used to test correlation between continuous variables. Statistical significance was considered to be a P value of < 0.05. All the statistical analyses were performed using the SPSS version 13.0 program package.

Results

Our sample consisted of 36 (72%) men and 14 (28%) women, with mean age of 42.5 ± 16.6 years, undergoing maintenance HD for 32.4 ± 34.7 months. Primary renal diseases were glomerulonephritis in 17 (34%), hypertensive nephrosclerosis in 12 (24%), diabetes in 12 (24%), obstructive nephropathy in 6 (12%) and undetermined in 3 (6%). Patients had mean body mass index within normal range (22.4 ± 4.1).

The laboratory results were hemoglobin of 10.1 ± 2.0 g/dl, albumin of 4.1 ± 0.7 g/dl, calcium of 9.2 ± 1.0 mg/dl, phosphorus of 4.7 ± 1.4 mg/dl and Kt/V of 1.4 ± 0.2.

Thirty-four (68%) patients were dyspeptic (PADYQ score ≥ 6). Mean PADYQ scores were 2.5 ± 2.3 and 16.8 ± 6.4 among non-dyspeptics and dyspeptics, respectively. There were no significant differences in the demographic and laboratory variables between patients with and without dyspepsia (Table 1).
Table 1

Sample characteristics according to dyspepsia

Variables

With dyspepsia

Without dyspepsia

P

Gender

  

0.508

Male

23 (67.6)

13 (81.3)

 

Female

11 (32.4)

3 (18.8)

 

Age

39.6 ± 16.5

48.6 ± 15.5

0.075

Etiology of ESRD

   

Glomerulonephritis

14 (41.2)

3 (18.8)

0.200

Hypertension

9 (26.5)

3 (18.8)

0.728

Diabetes

6 (17.6)

6 (37.5)

0.163

Obstructive uropathy

3 (18.8)

3 (18.8)

0.370

Undetermined

2 (5.9)

1 (6.3)

1.000

Months on dialysis

31.9 ± 30.7

33.5 ± 43.1

0.877

Using antacids

21 (61,7)

4 (25,0)

0.173

Number of medications

3.3 ± 0.9

3.6 ± 0.8

0.972

Body mass index (kg/m2)

22.3 ± 4,5

22.6 ± 3.3

0.897

Creatinine (mg/dl)

8.5 ± 2.9

8.1 ± 2.4

0.611

Hemoglobin (g/dl)

9.8 ± 2.1

10.9 ± 1.5

0.075

Albumin (g/dl)

4.1 ± 0.7

4.2 ± 0.8

0.571

Calcium (mg/dl)

9.1 ± 1.0

9.5 ± 1.0

0.155

Phosphorus (mg/dl)

4.9 ± 1.5

4.2 ± 1.1

0.115

Kt/V

1.4 ± 0.2

1.4 ± 0.2

0.965

Data are means ± SD, or percentages (in parentheses).

ESRD, End-stage renal disease.

The breath test was well tolerated by all participants and did not cause any adverse reactions.

Gastric emptying time estimated by t1/2 was different between dyspeptics and non-dyspeptics, respectively 238.0 ± 92.9 vs. 185.5 ± 45.5 minutes (p = 0.042) (Figure 1). According to the cut-off point of 200 minutes to classify gastric emptying delay, the mean t1/2 indicated gastric emptying delay among dyspeptics but not among non-dyspeptics. Additionally, the t1/2 was positively correlated with dyspepsia score (r = 0.366; p = 0.009) (Figure 2).
Figure 1

Comparison of t1/2 between dyspeptics and non-dyspeptics.

Figure 2

Correlation between t1/2 and dyspepsia scores.

Discussion

Our results confirmed the hypothesis that gastric emptying delay is associated with dyspepsia among ESRD patients on HD. First, we found longer gastric emptying time in dyspeptics compared to non-dyspeptics. Indeed, among dyspeptics, mean gastric emptying time was above the cut-off of 200 minutes, which classifies gastric emptying delay [14]. On the other hand, mean gastric emptying time was below 200 minutes in non-dyspeptics. Second, there was a positive correlation between gastric emptying time and dyspepsia score (higher score associated with more dyspeptic symptoms).

Due to its high prevalence and potential clinical importance, practitioners should pay attention to dyspepsia among the various ESRD patient symptoms. The prevalence of 68% in our study is within the range found in the literature, from 48% to 70% [3, 4]. Dyspeptic symptoms can negatively affect quality of life and psychological well-being in the general population as well as in ESRD patients [5, 17]. Awareness of the most common mechanisms involved in dyspepsia generation is crucial for successful management of dyspepsia. In theory, improvement of dyspepsia could ameliorate patients’ quality of life.

Unfortunately, gastric emptying delay, a suggested mechanism provoking dyspepsia, is difficult to assess in daily practice. The breath test we used is safe, but likely not suitable for larger samples due to the cost and need to spend extensive time for each evaluation.

Although we found a significant positive and linear correlation between t1/2 and dyspepsia score, we cannot ignore the overlap of gastric emptying time between the groups with and without dyspepsia (Figure 1). This is expected when studying dyspepsia, which is known to have multifactorial causes. Further studies are necessary to confirm gastric emptying delay as a main cause of dyspepsia among patients on HD and to formulate recommendations for appropriate treatment.

Even with a small size, our sample is larger compared to prior studies [1820]. Indeed, to the best of our knowledge this study involves the first clinical sample of Brazilian HD patients submitted to an evaluation of gastric emptying rate using the 13carbon octanoic acid breath test. We are aware of limitations. First, the PAQYQ was validated in a group of Brazilian patients with nonulcer dyspepsia and healthy volunteers, but not specifically among ESRD patients. Second, it would be better to study diabetics and non-diabetics separately because diabetics are likely to present more gastroparesis than non-diabetics. However, our resources limited us to 50 experiments. Thus, random selection was used and generated a typical HD sample from underdeveloped regions with 25% diabetics. Third, only routine laboratory variables were evaluated. If we could test other laboratory variables such as gastrointestinal peptide and cytokines levels, it would help to elucidate the mechanisms involved in the relationship of dyspepsia, gastric emptying and renal failure.

As a preliminary study, we believe the clinical implications that must be highlighted are that practitioners should routinely search for symptoms of dyspepsia in HD patients. Dyspepsia is highly prevalent and easy to assess. Second, the treatment of dyspepsia could improve quality of life in HD patients. Third, the use of prokinetics in cases of proven functional dyspepsia, when other treatments of dyspeptic symptoms are not successful, will depend on further studies confirming the role of gastric emptying time as an independent cause of dyspepsia.

Conclusions

Functional dyspepsia is very prevalent and is associated with gastric emptying delay. We assessed gastric emptying time by the octanoic acid breath test in a sample of ESRD on HD. Our findings raise the question about the role of prokinetics when the usual treatment of dyspeptic symptoms is not successful in proven functional dyspepsia cases. Future research is needed with larger samples, using a more workable method of measuring gastric emptying time.

Abbreviations

CO2: 

Carbon dioxide

ESRD: 

End-stage renal disease

HD: 

Hemodialysis

PADYQ: 

Porto Alegre dyspeptic symptoms questionnaire

T1/2: 

Time in minutes to metabolize the first half of the 13carbon dose in the test meal.

Declarations

Acknowledgements

We are grateful to Professor Vicente de Paulo Teixeira Pinto and Professor Mirna Marques Bezerra of Sobral School of Medicine, Federal University of Ceará, for their valuable critical opinions about the study.

Authors’ Affiliations

(1)
Sobral School of Medicine, Federal University of Ceará
(2)
Department of Physiology and Pharmacology, Federal University of Ceará

References

  1. Shiazian S, Radhakrishnan J: Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol. 2010, 6: 480-492. 10.1038/nrneph.2010.84.View ArticleGoogle Scholar
  2. Sander GB, Mazzoleni LE, Francesconi CFM, Wortmann AEC, Andreott E, Theil A, Piccoli VC, Silva AC, Oliveira L, Beheregaray S, Matioti S, Somm G, Goldim JR: Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: the Porto Alegre dyspeptic symptoms questionnaire (PADYQ). Dig Dis Sci. 2004, 49: 1822-1829. 10.1007/s10620-004-9578-z.View ArticlePubMedGoogle Scholar
  3. Van Vlem B, Schoonjans RS, Vanholder RC, Vos MD, Vandamme W, Van Laecke S, Lameire NH: Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis. 2000, 36: 962-968. 10.1053/ajkd.2000.19094.View ArticlePubMedGoogle Scholar
  4. Cano AE, Neil AK, Kang JY, Barrabas A, Eastwood JB, Nelson SR, Hartley I, Maxwell D: Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol. 2007, 102: 1990-1997. 10.1111/j.1572-0241.2007.01321.x.View ArticlePubMedGoogle Scholar
  5. Aro P, Talley NJ, Agréus L, Johansson SE, Bolling-Sternevald E, Storskrubb T, Ronkainen J: Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011, 33: 1215-1224. 10.1111/j.1365-2036.2011.04640.x.View ArticlePubMedGoogle Scholar
  6. Broker LE, Hurenkamp GJB, Riet G, Schellevis FG, Grundmeijer HG, Weert HC: Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study. BCM Farm Pract. 2009, 10: 1-8.Google Scholar
  7. Strid H, Simrén M, Stotzer PO, Abrahamsson H, Bjornsson ES: Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol. 2004, 6: 516-520.View ArticleGoogle Scholar
  8. Parkman HP, Jones MP: Reviews in basic and clinical gastroenterology. Gastroenterology. 2009, 138: 1526-1543.View ArticleGoogle Scholar
  9. Abell TL, Camilleri M, Donokoe K: Consensus recommendation for gastric emptying scintigraphy: a joint of the American Neurogastroenterology and Motility Society and the Sociey of Nuclear Medicine. Am J Gastroenterol. 2008, 103: 753-763. 10.1111/j.1572-0241.2007.01636.x.View ArticlePubMedGoogle Scholar
  10. Willems M, Quartero O, Numans M: How useful is the paracetamol absorption as a marker of gastric emptying? A systematic literature study. Dig Dis Sci. 2001, 46: 2256-2262. 10.1023/A:1011935603893.View ArticlePubMedGoogle Scholar
  11. Gentilcore D, Hausken T, Horowitz M: Measurement of gastric empyting of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in health subjects. Neurogastroenterol Motil. 2006, 18: 1062-1068. 10.1111/j.1365-2982.2006.00830.x.View ArticlePubMedGoogle Scholar
  12. Schwizer W, Maecke H, Fried M: Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology. 1992, 103: 369-376.View ArticlePubMedGoogle Scholar
  13. Kuo B, McCallum RW, Koch KL: Comparison of a gastric emptying of a non digestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008, 27: 186-196.View ArticlePubMedGoogle Scholar
  14. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G: Measurement of gastric emptying rate of solids by means of a carbon-labelled octanoic acid breath test. Gastroenterology. 1993, 104: 1640-1647.View ArticlePubMedGoogle Scholar
  15. Lee JS, Camilleri M, Zinsmeister AR: A valid, accurate, office-based, nonradioactive test for gastric emptying of solids. Gut. 2000, 46: 768-773. 10.1136/gut.46.6.768.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt-V: an analysis of error. J Am Soc Nephrol. 1993, 4: 205-213.Google Scholar
  17. Strid H, Simrém M, Johansson A, Svedlund J, Samuelsson O, Bjornsson ES: The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological well-being. Nephrol Dial Transplant. 2002, 17: 1434-1439. 10.1093/ndt/17.8.1434.View ArticlePubMedGoogle Scholar
  18. McNamee PT, Moore GW, McGeown MG, Doherty CC: Gastric emptying in chronic renal failure. Br Med J. 1985, 291: 310-311. 10.1136/bmj.291.6491.310.View ArticleGoogle Scholar
  19. Freeman JG, Cobden I, Heaton A, Keir M: Gastric emptying in chronic renal failure. Br Med J. 1985, 291: 1048-View ArticleGoogle Scholar
  20. Soffer EE, Geva B, Helman C, Avni Y, Bar-Meir S: Gastric emptying in chronic renal failure patients on hemodialysis. J Clin Gastroenterol. 1987, 9: 651-653. 10.1097/00004836-198712000-00008.View ArticlePubMedGoogle Scholar
  21. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/14/275/prepub

Copyright

© Salles Junior et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.